PEAK PHARMACEUTICALS, INC. Induced Conversion of Convertible Debt Expense
PEAK PHARMACEUTICALS, INC. (RMHI) reported Induced Conversion of Convertible Debt Expense of -$24.65 thousand for the 12-month period ending 2014-09-30, per its 10-K filed 2016-01-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2016-01-13
- PEAK PHARMACEUTICALS, INC. induced conversion of convertible debt expense for fiscal 2014 was -$24.65K.
| Period end | Induced Conversion of Convertible Debt Expense 12 month |
|---|---|
| 2014-09-30 | -$24.65K 10-K · filed 2016-01-13 |